Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1967 1
1968 1
1969 2
1970 5
1973 1
1977 1
1978 1
1979 1
1981 1
1987 1
1996 2
1999 1
2003 1
2005 2
2006 2
2007 1
2010 3
2012 1
2013 2
2014 2
2015 2
2016 4
2017 4
2018 8
2019 14
2020 7
2021 12
2022 10
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Oseltamivir for influenza.
Kubo K, Otsu S, Komiya N. Kubo K, et al. Among authors: otsu s. Lancet. 2015 Sep 19;386(9999):1135. doi: 10.1016/S0140-6736(15)00203-2. Lancet. 2015. PMID: 26461901 No abstract available.
Progress towards rabies control and elimination in Vietnam.
Nguyen HTT, Afriyie DO, Tran CH, Dang AD, Tran DN, Dang TQ, Otsu S, Urabe MI, Pham TN, Nguyen HT, Nguyen TTT, Nguyen TN, Padungtod P, Nguyen HT, Nguyen TTT, Nguyen HV, Le HT, Nguyen HT. Nguyen HTT, et al. Among authors: otsu s. Rev Sci Tech. 2019 May;38(1):199-212. doi: 10.20506/rst.38.1.2953. Rev Sci Tech. 2019. PMID: 31564730 Free article. Review.
Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel.
Ide Y, Otsuka T, Shimokawa M, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S, Fukahori M, Makiyama A, Shinohara Y, Ueno S, Taguchi H, Honda T, Shibuki T, Nio K, Ureshino N, Mizuta T, Mitsugi K, Shirakawa T. Ide Y, et al. Among authors: otsu s. Anticancer Res. 2023 Apr;43(4):1817-1826. doi: 10.21873/anticanres.16335. Anticancer Res. 2023. PMID: 36974805
Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.
Fukahori M, Okabe Y, Shimokawa M, Otsuka T, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S, Makiyama A, Taguchi H, Honda T, Ushijima T, Miwa K, Shibuki T, Nio K, Ide Y, Ureshino N, Mizuta T, Mitsugi K, Shirakawa T. Fukahori M, et al. Among authors: otsu s. Sci Rep. 2023 Nov 8;13(1):19399. doi: 10.1038/s41598-023-46924-0. Sci Rep. 2023. PMID: 37938630 Free PMC article.
Burden of Influenza-Associated Respiratory Hospitalizations, Vietnam, 2014-2016.
Khanh NC, Fowlkes AL, Nghia ND, Duong TN, Tu NH, Tu TA, McFarland JW, Nguyen TTM, Ha NT, Gould PL, Thanh PN, Trang NTH, Mai VQ, Thi PN, Otsu S, Azziz-Baumgartner E, Anh DD, Iuliano AD. Khanh NC, et al. Among authors: otsu s. Emerg Infect Dis. 2021 Oct;27(10):2648-2657. doi: 10.3201/eid2710.204765. Emerg Infect Dis. 2021. PMID: 34545793 Free PMC article.
Corticosteroid-dependent tuberculous meningitis: A case report.
Machida A, Amano E, Otsu S, Akagawa S. Machida A, et al. Among authors: otsu s. J Neurol Sci. 2019 Jan 15;396:232-234. doi: 10.1016/j.jns.2018.11.021. Epub 2018 Nov 17. J Neurol Sci. 2019. PMID: 30522040 No abstract available.
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Shirakawa T, Makiyama A, Shimokawa M, Otsuka T, Shinohara Y, Koga F, Ueda Y, Nakazawa J, Otsu S, Komori A, Arima S, Fukahori M, Taguchi H, Honda T, Shibuki T, Nio K, Ide Y, Ureshino N, Mizuta T, Mitsugi K, Akashi K, Baba E. Shirakawa T, et al. Among authors: otsu s. Sci Rep. 2023 May 31;13(1):8815. doi: 10.1038/s41598-023-34962-7. Sci Rep. 2023. PMID: 37258608 Free PMC article.
Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321.
Kasai T, Mori K, Nakamura Y, Seki N, Ichikawa Y, Saito H, Kondo T, Nishikawa K, Otsu S, Bessho A, Tanaka H, Yamaguchi H, Kaburagi T, Imai H, Mori K, Ohtake J, Okamoto H. Kasai T, et al. Among authors: otsu s. Cancer Med. 2023 Jul;12(14):14988-14999. doi: 10.1002/cam4.6135. Epub 2023 May 24. Cancer Med. 2023. PMID: 37226421 Free PMC article. Clinical Trial.
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.
Nishikawa K, Hironaka S, Inagaki T, Komori A, Otsu S, Mitsugi K, Makiyama A, Watanabe K, Tamura S, Okumura Y, Kusaba H, Esaki T, Baba E, Shirao K. Nishikawa K, et al. Among authors: otsu s. Jpn J Clin Oncol. 2022 Dec 5;52(12):1416-1422. doi: 10.1093/jjco/hyac143. Jpn J Clin Oncol. 2022. PMID: 36047806 Review.
97 results